Journal Article Summary
The article reviews the role of intravenous lipid emulsions (IVLEs) in preventing and treating liver disease associated with intestinal failure, known as intestinal failure-associated liver disease (IFALD). This condition can affect both pediatric and adult patients who rely on parenteral nutrition, which is nutrition delivered through an intravenous line. Understanding the causes and management of IFALD is crucial because it can lead to severe liver complications, including the need for liver transplants, and significantly impacts patient health and quality of life.
The authors summarize various studies and clinical findings related to lipid therapy in patients with IFALD. They highlight that fish oil-based lipid emulsions have shown promise in reversing liver damage caused by traditional soybean oil-based emulsions. Evidence from case reports and cohort studies indicates that switching to fish oil-based therapies can lead to a quicker resolution of cholestasis, a condition characterized by impaired bile flow, compared to soybean oil-based therapies. The article emphasizes the importance of early intervention and the potential benefits of using fish oil as a primary treatment option for patients at risk of developing liver disease from parenteral nutrition.
However, the article also notes several limitations, including the variability in patient responses to different lipid emulsions and the need for more extensive clinical trials to establish standardized treatment protocols. Patients and caregivers should consult healthcare professionals about the risks and benefits of different lipid therapies, especially if they are on long-term parenteral nutrition. Discussions should include monitoring liver function, potential side effects of lipid emulsions, and the importance of a multidisciplinary approach to managing IFALD effectively.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Rochling Fedja A.. Intravenous Lipid Emulsions in the Prevention and Treatment of Liver Disease in Intestinal Failure. Nutrients 2021. DOI: 10.3390/nu13030895. PMID: 33801970. PMCID: PMC7999390.
Featured Pill Pals Product
Omega 3 Acid Ethyl Esters --- 1 Gram --- Generic For Lovaza --- Epic Pharma
Omega 3 Acid Ethyl Esters — 1 Gram — Generic For Lovaza — Epic Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
